
Pharmaceuticals firm GSK has announced a shock change at the very top, with CEO Dame Emma Walmsley opting to step down after eight years in charge.
Chief commercial officer Luke Miels will be stepping up to lead the company instead, effective from 1 January, though Ms Walmsley will remain employed by the company until the end of September 2026.